rs730880629
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000256.3(MYBPC3):c.901A>T(p.Lys301*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000697 in 1,434,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000256.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.901A>T | p.Lys301* | stop_gained | Exon 9 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.901A>T | p.Lys301* | stop_gained | Exon 9 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.901A>T | non_coding_transcript_exon_variant | Exon 9 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000481 AC: 1AN: 208008Hom.: 0 AF XY: 0.00000895 AC XY: 1AN XY: 111790
GnomAD4 exome AF: 6.97e-7 AC: 1AN: 1434064Hom.: 0 Cov.: 33 AF XY: 0.00000141 AC XY: 1AN XY: 710522
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiomyopathy Pathogenic:2
This variant changes 1 nucleotide in exon 9 of the MyBP-C motif of the MYBPC3 gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with MYBPC3-related disorders in the literature. This variant has been identified in 1/208008 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MYBPC3 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
- -
not provided Pathogenic:2
Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease -
PVS1, PM2_supporting -
Hypertrophic cardiomyopathy Pathogenic:2
This variant changes 1 nucleotide in exon 9 of the MyBP-C motif of the MYBPC3 gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with MYBPC3-related disorders in the literature. This variant has been identified in 1/208008 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MYBPC3 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
This sequence change creates a premature translational stop signal (p.Lys301*) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). This variant is present in population databases (rs730880629, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with MYBPC3-related disease (internal data). ClinVar contains an entry for this variant (Variation ID: 181054). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Primary familial hypertrophic cardiomyopathy Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.K301* pathogenic mutation (also known as c.901A>T), located in coding exon 9 of the MYBPC3 gene, results from an A to T substitution at nucleotide position 901. This changes the amino acid from a lysine to a stop codon within coding exon 9. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at